Berichte.hochtief.de

Notes to the Consolidated Financial Statements Long-term Incentive Plan 2009
The Long-term Incentive Plan 2009 (LTIP 2009) was launched by resolution of the Supervisory Board in 2009 and
is open to Executive Board members and upper managerial employees of HOCHTIEF Aktiengesel schaft and its
affiliates. The conditions do not differ in any material respect from those of LTIP 2008. The maximum gain is set to
EUR 40.10 per stock award.
The SARs have been exercised in ful .
Long-term Incentive Plan 2010
The Long-term Incentive Plan 2010 (LTIP 2010) was launched by resolution of the Supervisory Board in 2010 and
is open to Executive Board members and upper managerial employees of HOCHTIEF Aktiengesel schaft and its
affiliates. Except for the longer waiting period (four years instead of two) for the SARs, the conditions do not differ
in any material respect from those of LTIP 2009. The maximum gain is set to EUR 81.83 per stock award.
Long-term Incentive Plan 2011
The Long-term Incentive Plan 2011 (LTIP 2011) was launched by resolution of the Supervisory Board in 2011 and is
open to Executive Board members and upper managerial employees of HOCHTIEF Aktiengesel schaft and its affili-
ates. The conditions do not differ in any material respect from those of LTIP 2010. The maximum gain is set to
EUR 98.01 per stock award.
Long-term Incentive Plan 2012
The Long-term Incentive Plan 2012 (LTIP 2012) was launched by resolution of the Supervisory Board in 2012 and is
open to Executive Board members and upper managerial employees of HOCHTIEF Aktiengesel schaft and its affili-
ates. The plan conditions differ from those of LTIP 2011 in two points:
1. Return on net assets (RONA) as per the most recently approved Consolidated Financial Statements must be at 2. The waiting time for stock awards was extended from three to four years and the total term of the plan accord- The maximum gain is set to EUR 75.81 per stock award.
Long-term Incentive Plan 2013
The Long-term Incentive Plan 2013 (LTIP 2013) was launched by resolution of the Supervisory Board in 2013 and is
open to Executive Board members. The plan conditions differ from those of LTIP 2012 in only one point:
The number of SARs that can be exercised depends on attainment of the planned value range for adjusted free cash flow. This value range is set in the business plan for each exercise year.
The maximum gain is set to EUR 73.83 per stock award.
Other information
The conditions of all plans stipulate that on the exercise of SARs or stock awards—and the fulfil ment of all other requisite criteria—HOCHTIEF Aktiengesel schaft normal y has the option of delivering HOCHTIEF shares instead of paying out the gain in cash. Where the entitled individuals are not employees of HOCHTIEF Aktiengesel schaft, the expense incurred on exercise of SARs or stock awards is met by the affiliated company concerned.
Annual Report 2013

Source: http://www.berichte.hochtief.de/ar13/data/pdf/pages/ar13_en-181.pdf

Microsoft word - course description 010909 _2_.doc

“How to Really Start Your Own Business” It’s been in the back of your mind for some time. It’s your dream… Whether it is to own your own business or to enhance your business by developing a new division or line … NOW is the time to start making it a reality. Even if you don’t have a clue what you want to do, you can still set the groundwork NOW. Inc. Magazine’s “H

Plasmocin prot

Plasmocin™ For treatment and prevention of Mycoplasma contamination of cel culture PRODUCT INFORMATION In contrast to most anti-Mycoplasma compounds that act solely in Content: vitro , Plasmocin™ is active on Mycoplasma present in cel culture Plasmocin™ is supplied as 1 ml tubes containing a sterile, yel ow medium, and on intracel ular Mycoplasma found in some specialized

© 2010-2018 Modern Medicine